Skip to main content Accessibility help
×
Home

Tauopathies: One Disease or Many?

  • Manon Bouchard (a1) and Oksana Suchowersky (a1) (a2)

Abstract

Tauopathies are a group of disorders that have in common abnormal accumulation of tau protein in the brain. Although the different tauopathies have long been considered to be separate diseases, it is now clear that progressive supranuclear palsy, corticobasal degeneration and some forms of tau-positive frontotemporal lobar degeneration share clinical, pathological and genetic features. The important overlap between these disorders suggest they may represent different phenotypes of a single disease process, the clinical result depending on the topography of pathological lesions as well as other unknown factors.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Tauopathies: One Disease or Many?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Tauopathies: One Disease or Many?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Tauopathies: One Disease or Many?
      Available formats
      ×

Copyright

Corresponding author

3350 Hospital DR NW, Calgary, Alberta, T2N 4Z5, Canada

References

Hide All
1.Williams, DR.Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36(10):652–60.
2.Gu, Y, Oyama, F, Ihara, Y.Tau is widely expressed in rat tissues. J Neurochem. 1996;67(3):1235–44.
3.Müller, R, Heinrich, M, Heck, S, Blohm, D, Richter-Landsberg, C.Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res. 1997;288 (2):239–49.
4.Couchie, D, Charrière-Bertrand, C, Nunez, J.Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J Neurochem. 1988;50(6):1894–9.
5.Hirokawa, N.Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol. 1994;6(1): 7481.
6.van Herpen, E, Rosso, SM, Serverijnen, L, et al.Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol. 2003;54(5):573–81.
7.Josephs, K.Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64(1):414.
8.Schrag, A, Ben-Shlomo, Y, Quinn, NP.Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354(9192):1771–5.
9.Steele, JC, Richardson, JC, Olszewski, J.Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964;10:333–59.
10.Williams, DR, Lees, AJ.Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270–9.
11.Litvan, I, Agid, Y, Calne, D, et al.Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):19.
12.Rivaud-Péchoux, S, Vidailhet, M, Gallouedec, G, et al.Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000;54(5):1029–32.
13.Vidailhet, M, Rivaud, S, Gouider-Khouja, N, et al.Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35(4):420–6.
14.Litvan, I, Grimes, DA, Lang, AE, et al.Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Neurology. 1999;246 Suppl II:15.
15.Scaravilli, T, Tolosa, E, Ferrer, I.Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov. Disord. 2005;20 Suppl 1:S21–8.
16.Josephs, KA, Duffy, JR.Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol. 2008;21(6): 688–92.
17.Kaat, LD, Boon, AJ, Kamphorst, W, et al.Frontal presentation in progressive supranuclear palsy. Neurology. 2007;69(8):723–9.
18.Maher, E, Smith, E, Lees, A.Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry. 1985: Dec;48(12):1234–9.
19.Grafman, J, Litvan, I, Gomez, C, Chase, TN.Frontal lobe function in progressive supranuclear palsy. Arch Neurol. 1990;47(5):553–8.
20.Kertesz, A, McMonagle, P.Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci. 2010;289(1-2):138–43.
21.Birdi, S, Rajput, A, Fenton, M, et al.Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord. 2002 Nov;17(6):1255–64.
22.Dubas, F, Gray, F, Escourolle, R.Steele-Richardson-Olszewski disease without ophthalmoplegia. 6 clinico-anatomic cases. Rev Neurol (Paris). 1983;139(6-7):407–16.
23.Davis, P, Bergeron, C, McLachlan, D.Atypical presentation of progressive supranuclear palsy. Ann Neurol. 1985 Apr;17(4): 337–43.
24.Daniel, SE, de Bruin, VM, Lees, AJ.The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995;118 (Pt 3:759–70.
25.Williams, DR, de Silva, R, Paviour, DC, et al.Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain. 2005;128(Pt 6):1247–58.
26.Barclay, CL, Bergeron, C, Lang, AE.Arm levitation in progressive supranuclear palsy. Neurology. 1999;52(4):879–82.
27.Oide, T, Ohara, S, Yazawa, M, et al.Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol. 2002 Aug;104(2):209–14. Epub 2002 Jun 5.
28.Motoi, Y, Takanashi, M, Itaya, M, et al.Glial localization of four-repeat tau in atypical progressive supranuclear palsy. Neuropathology. 2004;24(1):60–5.
29.Mizuno, T, Shiga, K, Nakata, Y, et al.Discrepancy between clinical and pathological diagnoses of CBD and PSP. J Neurol. 2005;252 (6):687–97.
30.Barclay, CL, Lang, AE.Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1997;62(4):352–6.
31.Boeve, BF, Maraganore, DM, Parisi, JE, et al.Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53(4):795800.
32.Nath, U, Ben-Shlomo, Y, Thomson, RG, Lees, AJ, Burn, DJ.Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology. 2003;60(6):910–6.
33.Masliah, E, Hansen, L, Quijada, S, et al.Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol. 1991 Apr;29(4): 389–96.
34.Keith-Rokosh, J, Ang, LC.Progressive supranuclear palsy: a review of co-existing neurodegeneration. Can J Neurol Sci. 2008;35(5): 602–8.
35.Josephs, KA, Petersen, RC, Knopman, DS, et al.Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41–8.
36.Josephs, K, Boeve, BF, Duffy, JR, et al.Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11(4):283–96.
37.Kertesz, A, McMonagle, P, Blair, M, Davidson, W, Munoz, DG.The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):19962005.
38.Knibb, JA, Xuereb, JH, Patterson, K, Hodges, JR.Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59(1):156–65.
39.Mochizuki, A, Ueda, Y, Komatsuzaki, Y, et al.Progressive supranuclear palsy presenting with primary progressive aphasia—clinicopathological report of an autopsy case. Acta Neuropathol. 2003 Jun;105(6):610–4. Epub 2003 Apr 1.
40.Boeve, B, Dickson, D, Duffy, J, et al.Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol. 2003;49 (2):72–8.
41.Josephs, KA, Dickson, DW.Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord. 2003;18(9):1018–26.
42.Osaki, Y, Ben-Shlomo, Y, Lees, AJ, et al.Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord. 2004; 19(2):181–9.
43.Gearing, M, Olson, D, Watts, R, Mirra, S.Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology. 1994 Jun;44(6):1015–24.
44.Shiozawa, M, Fukutani, Y, Sasaki, K, et al.Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin Neuropathol. 2000 Jul-Aug;19(4):192–9.
45.Ludolph, AC, Kassubek, J, Landwehrmeyer, BG, et al.Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009; 16(3):297309.
46.Hauw, J, Daniel, S, Dickson, D, et al.Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994 Nov;44(11):2015–9.
47.Feany, M, Mattiace, L, Dickson, D.Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol. 1996 Jan;55(1):5367.
48.Litvan, I, Hauw, JJ, Bartko, JJ, et al.Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55(1):97105.
49.Wakabayashi, K, Takahashi, H.Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology. 2004 Mar;24(1):7986.
50.Cordato, N, Halliday, G, McCann, H, et al.Corticobasal syndrome with tau pathology. Mov Disord. 2001 Jul;16(4):656–67.
51.Bergeron, C, Pollanen, MS, Weyer, L, Lang, AE.Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol. 1997;56(6):726–34.
52.Tsuboi, Y, Josephs, KA, Boeve, BF, et al.Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005;20(8):982–8.
53.Ikebe, S, Mori, H, Sumino, S, et al.A 77-year-old man with gait and gaze disturbance. Nō to Shinkei. 2000;52(3):269–79.
54.Williams, DR, Holton, JL, Strand, C, et al.Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain. 2007;130(Pt 6):1566–76.
55.Williams, DR, Holton, JL, Strand, K, Revesz, T, Lees, AJ.Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord. 2007;22(15): 2235–41.
56.Jellinger, K.Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis. 2008;5(6):339–46. Epub 2008 Mar 18.
57.Rebeiz, JJ, Kolodny, EH, Richardson, EP.Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18 (1):2033.
58.Gibb, WR, Luthert, PJ, Marsden, CD.Corticobasal degeneration. Brain. 1989;112 (Pt 5):1171–92.
59.Wenning, GK, Litvan, I, Jankovic, J, et al.Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998;64(2):184–9.
60.Wadia, P, Lang, A.The many faces of corticobasal degeneration. Parkinsonism Relat Disord. 2007;13 Suppl 3:S336–40.
61.Lang, A, Riley, D, Bergeron, C.Cortical-basal ganglionic degeneration. In: Clane, DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994:877–94.
62.Grimes, DA, Lang, AE, Bergeron, CB.Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53(9):1969–74.
63.Kertesz, A, Martinez-Lage, P, Davidson, W, Munoz, DG.The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology. 2000;55(9): 1368–75.
64.Pillon, B, Blin, J, Vidailhet, M, et al.The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology. 1995 Aug;45(8):1477–83.
65.Dubois, B, Slachevsky, A, Litvan, I, Pillon, B.The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621–6.
66.Kertesz, A, Munoz, D.Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord. 2004;17(4):282–6.
67.Blake, M, Duffy, J, Boeve, B, Ahlskog, E, Maraganore, D.Speech and language disorders associated with corticobasal degeneration. J Med Speech Lang Pathol 2003;11:131–46.
68.McMonagle, P, Blair, M, Kertesz, A.Corticobasal degeneration and progressive aphasia. Neurology. 2006;67(8):1444–51.
69.Grimes, DA, Lang, AE, Bergeron, CB.Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53(9):1969-.
70.Hodges, JR, Davies, RR, Xuereb, JH, et al.Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56(3): 399406.
71.Renner, J, Burns, J, Hou, C, et al.Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology. 2004 Oct 12; 63(7):1175–80.
72.Tang-Wai, D, Graff-Radford, N, Boeve, B, et al.Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004 Oct 12;63(7):1168–74.
73.Ikeda, K, Akiyama, H, Iritani, S, et al.Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol. 1996;92(5):534–9.
74.Sakurai, Y, Hashida, H, Uesugi, H, et al.A clinical profile of corticobasal degeneration presenting as primary progressive aphasia. Eur Neurol. 1996;36(3):134–7.
75.Bergeron, C, Pollanen, MS, Weyer, L, Black, SE, Lang, AE.Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol. 1996;40(6):893900.
76.Mimura, M, Oda, T, Tsuchiya, K, et al.Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study. J Neurol Sci. 2001 Jan 15;183(1): 1926.
77.Mathuranath, PS, Xuereb, JH, Bak, T, Hodges, JR.Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry. 2000;68(3):304–12.
78.Revesz, T, Holton, JL.Anatamopathological spectrum of tauopathies. Mov Disord. 2003;18 Suppl 6:S1320.
79.Tsuchiya, K, Ikeda, K, Uchihara, T, Oda, T, Shimada, H.Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan. Acta Neuropathol. 1997;94(5):416–24.
80.Ikeda, K.Basic pathology of corticobasal degeneration. Neuropathology 1997;17:127–33.
81.Wakabayashi, K, Oyanagi, K, Makifuchi, T, et al.Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. 1994;87(6):545–53.
82.Su, M, Yoshida, Y, Hirata, Y, Satoh, Y.An autopsy case of corticobasal degeneration associated with atrophy of pons and cerebellum. Niigata Medical J. 1999;113:350–1.
83.Ohara, S, Tsuyuzaki, J, Oide, T, et al.A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration? Neurosci Lett. 2002;330(1):84–8.
84.Hattori, M, Yoshida, M, Ojika, K, et al.An autopsy case of corticobasal degeneration without prominent cortical pathology-an imitator of progressive supranuclear palsy. Rinshō Shinkeigaku. 2000;40(4):372–7.
85.Neary, D, Snowden, JS, Gustafson, L, et al.Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–54.
86.Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57(4):416–8.
87.Schneider, J, Watts, R, Gearing, M, Brewer, R, Mirra, S.Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997 Apr;48(4):959–69.
88.Rinne, JO, Lee, MS, Thompson, PD, Marsden, CD.Corticobasal degeneration. Aclinical study of 36 cases. Brain. 1994;117 (Pt 5: 1183–96.
89.McKhann, GM, Albert, MS, Grossman, M, et al.Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58(11):1803–9.
90.Forman, MS, Farmer, J, Johnson, JK, et al.Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006;59(6): 952–62.
91.Josephs, K, Duffy, J, Strand, E, et al.Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006 Jun;129(Pt 6):1385–98.
92.Kertesz, A, Davidson, W, Munoz, DG.Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:46–9.
93.Dumanchin, C, Camuzat, A, Campion, D, et al.Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet. 1998;7(11):1825–9.
94.Hutton, M, Lendon, CL, Rizzu, P, et al.Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–5.
95.Bugiani, O, Murrell, JR, Giaccone, G, et al.Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol. 1999;58(6):667–77.
96.Soliveri, P, Rossi, G, Monza, D, et al.A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol. 2003;60(10): 1454–6.
97.Rademakers, R, Cruts, M, van Broeckhoven, C.The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Human Mutation. 2004;24(4):277–95.
98.Ferrer, I, Pastor, P, Rey, MJ, et al.Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol Appl Neurobiol. 2003;29(1):2334.
99.Pastor, P, Pastor, E, Carnero, C, et al.Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol. 2001;49(2): 263–7.
100.Rossi, G, Marelli, C, Farina, L, et al.The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov Disord. 2008 Apr 30;23(6):892–5.
101.Stanford, P, Halliday, G, Brooks, W, et al.Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain. 2000 May;123 (Pt 5):880–93.
102.Bird, TD, Nochlin, D, Poorkaj, P, et al.A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain. 1999;122 (Pt 4:741–56.
103.Ksiezak-Reding, H, Morgan, K, Mattiace, LA, et al.Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol. 1994;145(6):1496–508.
104.Buée Scherrer, V, Hof, PR, Buée, L, et al.Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease. Acta Neuropathol. 1996;91(4):351–9.
105.Buée, L, Delacourte, A.Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick’s disease. Brain Pathol. 1999;9(4):681–93.
106.Tellez-Nagel, I, Wiśniewski, H.Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol. 1973 Nov;29(5):324–7.
107.Arai, T, Ikeda, K, Akiyama, H, et al.Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2003;105(5):489–98.
108.Berry, RW, Sweet, AP, Clark, FA, et al.Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. J Neurocytol. 2004;33(3):287–95.
109.Arai, T, Ikeda, K, Akiyama, H, et al.Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy. Neuroreport. 2001;12(5):935–8.
110.Arai, T, Ikeda, K, Akiyama, H, et al.Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol. 2004;55(1):72–9.
111.Tuite, PJ, Clark, HB, Bergeron, C, et al.Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol. 2005;62 (9):1453–7.
112.Li, F, Iseki, E, Kosaka, K, et al.Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. Clin Neuropathol. 1996 Nov-Dec;15(6):319–23.
113.Katsuse, O, Iseki, E, Arai, T, et al.4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 2003;106(3):251–60.
114.Tan, C, Piao, Y, Kakita, A, et al.Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? Acta Neuropathol. 2005;109(3): 329–38.
115.Di Maria, E, Tabaton, M, Vigo, T, et al.Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol. 2000 Mar;47(3):374–7.
116.Houlden, H, Baker, M, Morris, HR, et al.Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56(12):1702–6.
117.Baker, M, Litvan, I, Houlden, H, et al.Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8(4):711–5.
118.Conrad, C, Andreadis, A, Trojanowski, J, et al.Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997 Feb;41(2):277–81.
119.Morris, HR, Janssen, JC, Bandmann, O, et al.The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 1999;66(5):665–7.
120.Hughes, A, Mann, D, Pickering-Brown, S.Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp Neurol. 2003;181(1):12–6.
121.Panegyres, PK, Zafiris-Toufexis, K.Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neuro-degenerative disorders. Eur J Neurol. 2002;9(5):485–9.
122.Gallo, M, Tomaino, C, Puccio, G, et al.Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol Sci. 2010;31(1):6570.
123.Seelaar, H, Rohrer, JD, Pijnenburg, YAL, Fox, NC, van Swieten, JC.Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011 May;82(5):476–86. Epub 2010 Oct 22.

Related content

Powered by UNSILO

Tauopathies: One Disease or Many?

  • Manon Bouchard (a1) and Oksana Suchowersky (a1) (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.